Department of Surgery, Holbæk Hospital, Holbæk, Denmark.
Department of Surgery, Nordsjællands Hospital Hillerød, Hillerød, Denmark.
Ann Surg. 2020 Dec;272(6):941-949. doi: 10.1097/SLA.0000000000003724.
To investigate the influence of intravenous (iv) fluid volumes on the secretion of N-terminal-pro-brain natriuretic peptide (NT-Pro-BNP) in colorectal surgical patients and its association with cardiopulmonary complications (CPC). In addition, to examine if preoperative NT-Pro-BNP can predict the risk for postoperative CPC.
Blood samples from patients enrolled in a previously published clinical randomized assessor-blinded multicenter trial were analyzed. Included were adult patients undergoing elective colorectal surgery with the American-Society-of-Anesthesiologists-scores of 1-3. Samples from 135 patients were available for analysis. Patients were allocated to either a restrictive (R-group) or a standard (S-group) iv-fluid regimen, commencing preoperatively and continuing until discharge. Blood was sampled every morning until the fourth postoperative day. The primary outcome for this study was NT-Pro-BNP changes and its association with fluid therapy and CPC.
The S-group received more iv-fluid than the R-group on the day-of-surgery [milliliter, median (range) 6485 (4401-10750) vs 3730 (2250-8510); P < 0.001] and on the first postoperative day. NT-Pro-BNP was elevated in the S-group compared with the R-group on all postoperative days [area under the curve: median (interquartile range) pg/mL: 3285 (1697-6179) vs 1290 (758-3719); P < 0.001 and in patients developing CPC vs no-CPC (area under the curve), median (interquartile range): 5196 (1823-9061) vs 1934 (831-5301); P = 0.005]. NT-pro-BNP increased with increasing fluid volumes all days (P < 0.003). Preoperative NT-Pro-BNP predicted CPC [odds ratio (confidence interval): 1.573 (0.973-2.541), P = 0.032; positive predictive value = 0.257, negative predictive value = 0.929].
NT-pro-BNP increases with iv-fluid volumes given to colorectal surgical patients, and the level of NT-Pro-BNP is associated with CPC. Preoperative NT-Pro-BNP is predictive for CPC, but the diagnostic value is low.Clinicaltrials.gov NCT03537989.
研究结直肠外科患者静脉输液量对 N 端脑利钠肽前体(NT-Pro-BNP)分泌的影响及其与心肺并发症(CPC)的关系。此外,还研究术前 NT-Pro-BNP 是否可以预测术后 CPC 的风险。
对先前发表的临床随机评估者盲法多中心试验中的患者进行了血液样本分析。研究对象为接受择期结直肠手术、美国麻醉医师协会评分 1-3 分的成年患者。对 135 例患者的样本进行了分析。患者被分配到限制性(R 组)或标准(S 组)静脉输液方案中,在术前开始并持续到出院。每天早上采集血液,直到术后第 4 天。本研究的主要结果是 NT-Pro-BNP 的变化及其与液体治疗和 CPC 的关系。
手术当天和术后第 1 天,S 组接受的静脉输液量明显多于 R 组[毫升,中位数(范围):6485(4401-10750)比 3730(2250-8510);P<0.001]。与 R 组相比,S 组在所有术后日 NT-Pro-BNP 水平均升高[曲线下面积:中位数(四分位距)pg/mL:3285(1697-6179)比 1290(758-3719);P<0.001],并且在发生 CPC 与无 CPC 的患者中也存在差异(曲线下面积),中位数(四分位距):5196(1823-9061)比 1934(831-5301);P=0.005]。NT-pro-BNP 与每天增加的液体量呈正相关(P<0.003)。术前 NT-Pro-BNP 预测 CPC[比值比(置信区间):1.573(0.973-2.541),P=0.032;阳性预测值=0.257,阴性预测值=0.929]。
静脉输液量的增加与结直肠外科患者的 NT-Pro-BNP 水平升高有关,而 NT-Pro-BNP 水平与 CPC 有关。术前 NT-Pro-BNP 可预测 CPC,但诊断价值较低。Clinicaltrials.gov NCT03537989。